- Home
- EVAX vs WXM Comparison
EVAX vs WXM Comparison
Compare EVAX & WXM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- WXM
- Stock Information
- Founded
- EVAX 2008
- WXM 2009
- Country
- EVAX Denmark
- WXM China
- Employees
- EVAX N/A
- WXM N/A
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- WXM
- Sector
- EVAX Health Care
- WXM
- Exchange
- EVAX Nasdaq
- WXM NYSE
- Market Cap
- EVAX 16.3M
- WXM 15.3M
- IPO Year
- EVAX 2021
- WXM 2025
- Fundamental
- Price
- EVAX $1.64
- WXM $2.05
- Analyst Decision
- EVAX Strong Buy
- WXM
- Analyst Count
- EVAX 2
- WXM 0
- Target Price
- EVAX $10.00
- WXM N/A
- AVG Volume (30 Days)
- EVAX 64.1K
- WXM 144.1K
- Earning Date
- EVAX 05-27-2025
- WXM 01-01-0001
- Dividend Yield
- EVAX N/A
- WXM N/A
- EPS Growth
- EVAX N/A
- WXM 67.61
- EPS
- EVAX N/A
- WXM 0.18
- Revenue
- EVAX $3,344,000.00
- WXM $15,524,259.00
- Revenue This Year
- EVAX $102.45
- WXM N/A
- Revenue Next Year
- EVAX $100.30
- WXM N/A
- P/E Ratio
- EVAX N/A
- WXM $12.28
- Revenue Growth
- EVAX 4480.82
- WXM 10.86
- 52 Week Low
- EVAX $1.20
- WXM $1.52
- 52 Week High
- EVAX $20.81
- WXM $7.99
- Technical
- Relative Strength Index (RSI)
- EVAX 55.67
- WXM N/A
- Support Level
- EVAX $1.42
- WXM N/A
- Resistance Level
- EVAX $1.62
- WXM N/A
- Average True Range (ATR)
- EVAX 0.11
- WXM 0.00
- MACD
- EVAX 0.03
- WXM 0.00
- Stochastic Oscillator
- EVAX 62.86
- WXM 0.00
About EVAX Evaxion Biotech
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.
About WXM WF INTERNATIONAL LIMITED
WF International Ltd is engaged in the provision of supply, installation, fitting-out and maintenance services for HVAC system and floor heating systems. It provides the supply, installation and fitting-out services for HVAC systems for large-scaled commercial projects consisting of offices, hotels, manufactures, airports and hospitals, such as the International Finance Square HVAC projects across China, Chengdu Vanke Charm City, Chengdu Raffles Plaza, Chengdu Yinshi Plaza, Chengdu Metro No. Ten Line, and Panzhihua Jinhai Hotel.